Is Delko S.A.'s (WSE:DEL) Capital Allocation Ability Worth Your Time?

Today we are going to look at Delko S.A. (WSE:DEL) to see whether it might be an attractive investment prospect. Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business.

First of all, we'll work out how to calculate ROCE. Second, we'll look at its ROCE compared to similar companies. Last but not least, we'll look at what impact its current liabilities have on its ROCE.

Advertisement

Return On Capital Employed (ROCE): What is it?

ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business. Generally speaking a higher ROCE is better. Ultimately, it is a useful but imperfect metric. Author Edwin Whiting says to be careful when comparing the ROCE of different businesses, since 'No two businesses are exactly alike.

How Do You Calculate Return On Capital Employed?

Analysts use this formula to calculate return on capital employed:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Delko:

0.17 = zł21m ÷ (zł250m - zł131m) (Based on the trailing twelve months to September 2019.)

Therefore, Delko has an ROCE of 17%.

See our latest analysis for Delko

Is Delko's ROCE Good?

When making comparisons between similar businesses, investors may find ROCE useful. It appears that Delko's ROCE is fairly close to the Retail Distributors industry average of 17%. Regardless of where Delko sits next to its industry, its ROCE in absolute terms appears satisfactory, and this company could be worth a closer look.

The image below shows how Delko's ROCE compares to its industry, and you can click it to see more detail on its past growth.

WSE:DEL Past Revenue and Net Income, March 1st 2020
WSE:DEL Past Revenue and Net Income, March 1st 2020

When considering ROCE, bear in mind that it reflects the past and does not necessarily predict the future. Companies in cyclical industries can be difficult to understand using ROCE, as returns typically look high during boom times, and low during busts. ROCE is only a point-in-time measure. If Delko is cyclical, it could make sense to check out this free graph of past earnings, revenue and cash flow.

What Are Current Liabilities, And How Do They Affect Delko's ROCE?

Current liabilities are short term bills and invoices that need to be paid in 12 months or less. The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise. To check the impact of this, we calculate if a company has high current liabilities relative to its total assets.

Delko has total assets of zł250m and current liabilities of zł131m. As a result, its current liabilities are equal to approximately 52% of its total assets. Delko's current liabilities are fairly high, which increases its ROCE significantly.

Our Take On Delko's ROCE

While its ROCE looks decent, it wouldn't look so good if it reduced current liabilities. There might be better investments than Delko out there, but you will have to work hard to find them . These promising businesses with rapidly growing earnings might be right up your alley.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About WSE:DEL

Delko

Engages in the wholesale of household chemical, cosmetics, industrial, and hygiene products in Poland.

Excellent balance sheet with moderate risk and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7060.2% undervalued
25 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$317.226.4% undervalued
32 users have followed this narrative
7 users have commented on this narrative
10 users have liked this narrative
NI
niteco
AVGO logo
niteco on Broadcom ·

A Capital Allocation Favorite with Structural Importance

Fair Value:US$651.0542.8% undervalued
33 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
TO
Tokyo
OKTA logo
Tokyo on Okta ·

Good foundation, but now it's all about the next steps

Fair Value:US$15123.9% undervalued
85 users have followed this narrative
7 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

AN
AntonioS
CSL logo
AntonioS on CSL ·

CSL Investment Thesis

Fair Value:AU$14026.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7448.9% undervalued
58 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VA
Valtersa
4002 logo
Valtersa on Mouwasat Medical Services ·

Mouwasat Medical Services Will Achieve a 25% Profit Margin in Just 3 Years

Fair Value:ر.س98.634.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7448.9% undervalued
58 users have followed this narrative
0 users have commented on this narrative
15 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9724.0% undervalued
58 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1935.7% undervalued
48 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative